Cleared Traditional

NORAV HOLTER SYSTEM, MODEL NH-300 V1.07 (K012712) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K012712 · Norav Medical , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2002
Decision
267d
Days
Class 2
Risk

K012712 is an FDA 510(k) clearance for the NORAV HOLTER SYSTEM, MODEL NH-300 V1.07. Classified as Electrocardiograph, Ambulatory, With Analysis Algorithm (product code MLO), Class II - Special Controls.

Submitted by Norav Medical , Ltd. (Plymouth, US). The FDA issued a Cleared decision on May 8, 2002 after a review of 267 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Norav Medical , Ltd. devices

Submission Details

510(k) Number K012712 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2001
Decision Date May 08, 2002
Days to Decision 267 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
142d slower than avg
Panel avg: 125d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MLO Electrocardiograph, Ambulatory, With Analysis Algorithm
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MLO Electrocardiograph, Ambulatory, With Analysis Algorithm

All 31
Devices cleared under the same product code (MLO) and FDA review panel - the closest regulatory comparables to K012712.
Philips Holter Analysis System
K241890 · Philips Medizin Systeme B?blingen GmbH · Mar 2025
Frontier X Plus
K240794 · Fourth Frontier Technologies Pvt, Ltd. · Nov 2024
RX-1 Rhythm Express Remote Cardiac Monitoring System
K200833 · Vivaquant, Inc. · Sep 2020
CER-S
K193177 · Cardiocalm · Aug 2020
Faros Mobile
K182030 · Bittium Biosignals , Ltd. · Nov 2018